Trials / Completed
CompletedNCT00002408
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Shaman Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool weight in AIDS patients with diarrhea over 6 days of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Crofelemer |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
36 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00002408. Inclusion in this directory is not an endorsement.